REACTOME_TCR_SIGNALING |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
UBB |
Polyubiquitin-B |
[1] |
-1.23[2] |
-1.30[3] |
-1.14[4] |
-1.53[5] |
-1.14[6] |
-0.65[7] |
2 |
RPS27A |
Ubiquitin-40S ribosomal protein S27a |
[8] |
[9] |
[10] |
[11] |
[12] |
[13] |
[14] |
3 |
UBC |
Polyubiquitin-C |
[15] |
-0.79[16] |
-0.55[17] |
-0.78[18] |
-0.68[19] |
-0.76[20] |
-0.20[21] |
4 |
PSME1 |
Proteasome activator complex subunit 1 |
[22] |
-0.56[23] |
-2.14[24] |
-1.75[25] |
-1.40[26] |
-1.98[27] |
-1.15[28] |
5 |
PSME2 |
Proteasome activator complex subunit 2 |
[29] |
-0.38[30] |
-1.76[31] |
-1.84[32] |
-1.18[33] |
-1.52[34] |
-0.78[35] |
6 |
PSMA7 |
Proteasome subunit alpha type-7 |
[36] |
0.58[37] |
0.71[38] |
-0.59[39] |
0.44[40] |
-0.04[41] |
0.25[42] |
7 |
PSMB1 |
Proteasome subunit beta type-1 |
[43] |
0.13[44] |
0.26[45] |
-0.79[46] |
-0.80[47] |
-0.08[48] |
0.08[49] |
8 |
PSMB3 |
Proteasome subunit beta type-3 |
[50] |
-0.36[51] |
-1.12[52] |
-0.06[53] |
-0.82[54] |
-0.99[55] |
-0.21[56] |
9 |
PSMB4 |
Proteasome subunit beta type-4 |
[57] |
-0.11[58] |
0.08[59] |
0.24[60] |
0.61[61] |
0.55[62] |
-0.54[63] |
10 |
PSMB7 |
Proteasome subunit beta type-7 |
[64] |
-1.05[65] |
-1.02[66] |
-0.86[67] |
-1.17[68] |
-0.77[69] |
-0.98[70] |
11 |
PSMB5 |
Proteasome subunit beta type-5 |
[71] |
1.34[72] |
-0.06[73] |
-0.11[74] |
-0.44[75] |
-0.21[76] |
-0.51[77] |
12 |
PSMA6 |
Proteasome subunit alpha type-6 |
[78] |
1.47[79] |
0.22[80] |
0.18[81] |
0.08[82] |
0.06[83] |
-0.42[84] |
13 |
NFKBIA |
NF-kappa-B inhibitor alpha |
[85] |
-0.09[86] |
-1.75[87] |
-2.12[88] |
-2.27[89] |
-0.45[90] |
0.09[91] |
14 |
PSMA4 |
Proteasome subunit alpha type-4 |
[92] |
-0.46[93] |
0.23[94] |
0.06[95] |
0.39[96] |
0.17[97] |
-0.50[98] |
15 |
SKP1 |
S-phase kinase-associated protein 1 |
[99] |
-0.01[100] |
0.51[101] |
-0.35[102] |
0.74[103] |
0.90[104] |
0.53[105] |
16 |
PSMC3 |
26S proteasome regulatory subunit 6A |
[106] |
-0.49[107] |
-0.53[108] |
0.12[109] |
-0.81[110] |
-0.66[111] |
-0.03[112] |
17 |
PSMA3 |
Proteasome subunit alpha type-3 |
[113] |
-1.08[114] |
-0.05[115] |
-0.69[116] |
-0.07[117] |
-0.56[118] |
-0.26[119] |
18 |
PSMB6 |
Proteasome subunit beta type-6 |
[120] |
-0.53[121] |
-0.35[122] |
-0.18[123] |
-0.61[124] |
-0.92[125] |
-0.10[126] |
19 |
PSMA2 |
Proteasome subunit alpha type-2 |
[127] |
-0.61[128] |
0.37[129] |
0.74[130] |
-0.12[131] |
0.22[132] |
0.13[133] |
20 |
PSMD4 |
26S proteasome non-ATPase regulatory subunit 4 |
[134] |
-0.10[135] |
-0.05[136] |
0.18[137] |
0.59[138] |
0.01[139] |
-0.20[140] |
21 |
PSMD7 |
26S proteasome non-ATPase regulatory subunit 7 |
[141] |
-0.18[142] |
0.22[143] |
0.11[144] |
-0.50[145] |
-0.07[146] |
-0.37[147] |
22 |
PSMD8 |
26S proteasome non-ATPase regulatory subunit 8 |
[148] |
-0.01[149] |
0.26[150] |
0.43[151] |
-0.22[152] |
0.50[153] |
-0.35[154] |
23 |
PSMD2 |
26S proteasome non-ATPase regulatory subunit 2 |
[155] |
1.52[156] |
0.73[157] |
0.83[158] |
0.88[159] |
2.14[160] |
0.69[161] |
24 |
PSMC1 |
26S proteasome regulatory subunit 4 |
[162] |
-0.16[163] |
-0.06[164] |
-0.68[165] |
1.07[166] |
0.55[167] |
-0.15[168] |
25 |
PSMA1 |
Proteasome subunit alpha type-1 |
[169] |
0.03[170] |
0.45[171] |
0.54[172] |
0.64[173] |
0.11[174] |
0.34[175] |
26 |
UBA52 |
Ubiquitin-60S ribosomal protein L40 |
[176] |
1.65[177] |
1.69[178] |
2.73[179] |
0.72[180] |
1.47[181] |
0.57[182] |
27 |
PSMC5 |
26S proteasome regulatory subunit 8 |
[183] |
0.34[184] |
0.27[185] |
0.38[186] |
0.05[187] |
0.43[188] |
0.11[189] |
28 |
PSMD3 |
26S proteasome non-ATPase regulatory subunit 3 |
[190] |
0.74[191] |
0.26[192] |
0.89[193] |
0.58[194] |
0.77[195] |
-0.18[196] |
29 |
PSMB8 |
Proteasome subunit beta type-8 |
[197] |
-1.66[198] |
-2.22[199] |
-9.40[200] |
0.56[201] |
-0.79[202] |
-0.87[203] |
30 |
PSMD14 |
26S proteasome non-ATPase regulatory subunit 14 |
[204] |
-0.08[205] |
0.56[206] |
0.84[207] |
0.45[208] |
0.44[209] |
-0.32[210] |
31 |
PSMC4 |
26S proteasome regulatory subunit 6B |
[211] |
0.34[212] |
0.40[213] |
0.37[214] |
0.08[215] |
0.15[216] |
0.15[217] |
32 |
PSMD6 |
26S proteasome non-ATPase regulatory subunit 6 |
[218] |
-0.81[219] |
-0.30[220] |
-1.36[221] |
-0.55[222] |
0.22[223] |
-0.44[224] |
33 |
PSMD13 |
26S proteasome non-ATPase regulatory subunit 13 |
[225] |
0.39[226] |
0.53[227] |
1.06[228] |
0.51[229] |
-0.02[230] |
-0.25[231] |
34 |
PSMD12 |
26S proteasome non-ATPase regulatory subunit 12 |
[232] |
-0.43[233] |
-0.32[234] |
-0.60[235] |
0.13[236] |
0.16[237] |
-0.33[238] |
35 |
PSMC6 |
26S proteasome regulatory subunit 10B |
[239] |
-0.13[240] |
1.47[241] |
0.32[242] |
0.49[243] |
0.38[244] |
0.33[245] |
36 |
PSMD11 |
26S proteasome non-ATPase regulatory subunit 11 |
[246] |
0.75[247] |
0.39[248] |
1.01[249] |
0.89[250] |
1.01[251] |
1.15[252] |
37 |
UBE2V1 |
Ubiquitin-conjugating enzyme E2 variant 1 |
[253] |
-2.91[254] |
-2.96[255] |
-2.82[256] |
-2.64[257] |
-3.35[258] |
-3.79[259] |
38 |
VASP |
Vasodilator-stimulated phosphoprotein |
[260] |
0.83[261] |
0.57[262] |
0.93[263] |
1.02[264] |
0.08[265] |
-1.70[266] |
39 |
PSMC2 |
26S proteasome regulatory subunit 7 |
[267] |
0.50[268] |
0.93[269] |
0.74[270] |
1.29[271] |
1.08[272] |
1.20[273] |
40 |
HLA-DRA |
HLA class II histocompatibility antigen, DR alpha chain |
[274] |
-12.30[275] |
[276] |
-13.17[277] |
-4.50[278] |
-6.49[279] |
0.65[280] |
41 |
PSME3 |
Proteasome activator complex subunit 3 |
[281] |
1.73[282] |
1.48[283] |
1.19[284] |
1.31[285] |
1.54[286] |
0.77[287] |
42 |
CDC34 |
Ubiquitin-conjugating enzyme E2 R1 |
[288] |
0.76[289] |
1.06[290] |
0.31[291] |
-0.28[292] |
-0.58[293] |
-1.02[294] |
43 |
PSMD1 |
26S proteasome non-ATPase regulatory subunit 1 |
[295] |
1.49[296] |
1.84[297] |
1.75[298] |
2.12[299] |
2.09[300] |
1.96[301] |
44 |
IKBKG |
NF-kappa-B essential modulator |
[302] |
0.08[303] |
0.36[304] |
-1.88[305] |
0.40[306] |
-0.88[307] |
0.62[308] |
45 |
PSMB10 |
Proteasome subunit beta type-10 |
[309] |
-1.23[310] |
-0.61[311] |
-2.47[312] |
-0.09[313] |
-1.29[314] |
-0.19[315] |
46 |
PSMA5 |
Proteasome subunit alpha type-5 |
[316] |
1.82[317] |
2.27[318] |
1.87[319] |
2.17[320] |
1.70[321] |
1.80[322] |
47 |
PSMF1 |
Proteasome inhibitor PI31 subunit |
[323] |
2.20[324] |
2.27[325] |
1.11[326] |
1.18[327] |
0.90[328] |
1.74[329] |
48 |
UBE2N |
Ubiquitin-conjugating enzyme E2 N |
[330] |
1.66[331] |
2.26[332] |
1.09[333] |
1.57[334] |
1.39[335] |
0.51[336] |
49 |
HLA-DRB1 |
HLA class II histocompatibility antigen, DRB1-15 beta chain |
[337] |
-7.47[338] |
[339] |
[340] |
-4.86[341] |
-10.00[342] |
-0.43[343] |
50 |
PSMB2 |
Proteasome subunit beta type-2 |
[344] |
1.98[345] |
1.74[346] |
2.16[347] |
2.48[348] |
2.42[349] |
2.28[350] |
51 |
RELA |
Transcription factor p65 |
[351] |
1.10[352] |
0.73[353] |
0.87[354] |
1.19[355] |
1.04[356] |
0.34[357] |
52 |
CD4 |
T-cell surface glycoprotein CD4 |
[358] |
-4.79[359] |
-2.47[360] |
-5.09[361] |
-6.20[362] |
-8.32[363] |
1.14[364] |
53 |
PSMB9 |
Proteasome subunit beta type-9 |
[365] |
-2.03[366] |
-4.62[367] |
-6.90[368] |
1.73[369] |
-0.58[370] |
-0.61[371] |
54 |
PSMD9 |
26S proteasome non-ATPase regulatory subunit 9 |
[372] |
0.35[373] |
0.87[374] |
-0.08[375] |
0.35[376] |
0.75[377] |
0.61[378] |
55 |
CUL1 |
Cullin-1 |
[379] |
0.58[380] |
1.39[381] |
0.95[382] |
1.83[383] |
1.42[384] |
1.97[385] |
56 |
EVL |
Ena/VASP-like protein |
[386] |
-0.23[387] |
-4.59[388] |
-1.16[389] |
0.17[390] |
-0.91[391] |
0.30[392] |
57 |
NCK1 |
Cytoplasmic protein NCK1 |
[393] |
-0.63[394] |
-0.39[395] |
-0.28[396] |
0.69[397] |
0.73[398] |
0.75[399] |
58 |
PAK2 |
Serine/threonine-protein kinase PAK 2 |
[400] |
2.41[401] |
2.29[402] |
2.60[403] |
2.00[404] |
2.48[405] |
2.59[406] |
59 |
UBE2D2 |
Ubiquitin-conjugating enzyme E2 D2 |
[407] |
1.97[408] |
2.15[409] |
1.43[410] |
2.04[411] |
2.18[412] |
1.19[413] |
60 |
CSK |
Tyrosine-protein kinase CSK |
[414] |
1.34[415] |
0.97[416] |
1.35[417] |
1.24[418] |
0.77[419] |
0.36[420] |
61 |
PSMD10 |
26S proteasome non-ATPase regulatory subunit 10 |
[421] |
0.91[422] |
1.26[423] |
1.31[424] |
2.02[425] |
1.31[426] |
0.60[427] |
62 |
TAB2 |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 |
[428] |
1.33[429] |
1.63[430] |
1.90[431] |
2.95[432] |
2.34[433] |
1.47[434] |
63 |
MAP3K7 |
Mitogen-activated protein kinase kinase kinase 7 |
[435] |
0.87[436] |
2.07[437] |
1.95[438] |
1.74[439] |
1.85[440] |
1.47[441] |
64 |
PSME4 |
Proteasome activator complex subunit 4 |
[442] |
2.44[443] |
3.38[444] |
3.41[445] |
2.58[446] |
2.50[447] |
2.86[448] |
65 |
PIK3R1 |
Phosphatidylinositol 3-kinase regulatory subunit alpha |
[449] |
0.50[450] |
0.75[451] |
1.84[452] |
3.32[453] |
2.75[454] |
4.23[455] |
66 |
HLA-DPA1 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
[456] |
-5.97[457] |
-9.34[458] |
[459] |
-3.85[460] |
-5.77[461] |
0.94[462] |
67 |
HLA-DRB5 |
HLA class II histocompatibility antigen, DR beta 5 chain |
[463] |
-10.12[464] |
[465] |
[466] |
-7.11[467] |
[468] |
-4.62[469] |
68 |
PTEN |
Phosphatidylinositol
3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN |
0.43[470] |
1.95[471] |
2.16[472] |
0.68[473] |
1.87[474] |
3.70[475] |
69 |
NFKB1 |
Nuclear factor NF-kappa-B p105 subunit |
[476] |
1.64[477] |
1.45[478] |
1.24[479] |
1.00[480] |
1.85[481] |
1.67[482] |
70 |
PSMD5 |
26S proteasome non-ATPase regulatory subunit 5 |
[483] |
1.33[484] |
0.91[485] |
2.50[486] |
2.41[487] |
2.45[488] |
2.04[489] |
71 |
FBXW11 |
F-box/WD repeat-containing protein 11 |
[490] |
2.34[491] |
2.38[492] |
3.15[493] |
2.77[494] |
2.62[495] |
2.17[496] |
72 |
PIK3R2 |
Phosphatidylinositol 3-kinase regulatory subunit beta |
[497] |
2.84[498] |
3.20[499] |
3.81[500] |
1.96[501] |
2.45[502] |
0.93[503] |
73 |
RIPK2 |
Receptor-interacting serine/threonine-protein kinase 2 |
[504] |
0.40[505] |
1.13[506] |
1.14[507] |
1.05[508] |
0.95[509] |
0.09[510] |
74 |
ENAH |
Protein enabled homolog |
[511] |
4.50[512] |
2.51[513] |
4.61[514] |
5.33[515] |
4.31[516] |
1.83[517] |
75 |
CHUK |
Inhibitor of nuclear factor kappa-B kinase subunit alpha |
[518] |
1.87[519] |
3.22[520] |
3.19[521] |
1.90[522] |
2.65[523] |
2.74[524] |
76 |
PTPRJ |
Receptor-type tyrosine-protein phosphatase eta |
[525] |
-0.11[526] |
1.65[527] |
2.98[528] |
2.71[529] |
2.68[530] |
3.18[531] |
77 |
PDPK1 |
3-phosphoinositide-dependent protein kinase 1 |
[532] |
3.30[533] |
4.62[534] |
3.34[535] |
2.69[536] |
3.02[537] |
3.73[538] |
78 |
PLCG1 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase gamma-1 |
4.46[539] |
4.21[540] |
3.55[541] |
4.07[542] |
3.50[543] |
1.56[544] |
79 |
IKBKB |
Inhibitor of nuclear factor kappa-B kinase subunit beta |
[545] |
1.49[546] |
1.68[547] |
1.79[548] |
1.51[549] |
1.53[550] |
2.41[551] |
80 |
PIK3CB |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit beta isoform |
2.18[552] |
2.82[553] |
2.99[554] |
2.30[555] |
2.39[556] |
2.38[557] |
81 |
BCL10 |
B-cell lymphoma/leukemia 10 |
[558] |
1.06[559] |
0.69[560] |
1.69[561] |
1.79[562] |
1.76[563] |
1.76[564] |
82 |
HLA-DPB1 |
HLA class II histocompatibility antigen, DP beta 1 chain |
[565] |
-8.07[566] |
-9.01[567] |
[568] |
-2.69[569] |
-0.76[570] |
1.74[571] |
83 |
UBE2D1 |
Ubiquitin-conjugating enzyme E2 D1 |
[572] |
1.76[573] |
2.76[574] |
3.11[575] |
2.77[576] |
2.47[577] |
1.72[578] |
84 |
PAK1 |
Serine/threonine-protein kinase PAK 1 |
[579] |
0.96[580] |
0.33[581] |
2.74[582] |
-0.61[583] |
3.11[584] |
1.49[585] |
85 |
BTRC |
F-box/WD repeat-containing protein 1A |
[586] |
2.38[587] |
3.30[588] |
2.93[589] |
2.01[590] |
2.48[591] |
2.57[592] |
86 |
MALT1 |
Mucosa-associated lymphoid tissue
lymphoma translocation protein 1 |
3.82[593] |
3.80[594] |
3.23[595] |
3.29[596] |
2.51[597] |
3.49[598] |
87 |
HLA-DQA1 |
HLA class II histocompatibility antigen, DQ alpha 1 chain |
[599] |
[600] |
[601] |
[602] |
-5.53[603] |
-9.23[604] |
0.35[605] |
88 |
PIK3CA |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit alpha isoform |
0.59[606] |
2.36[607] |
2.55[608] |
2.38[609] |
2.52[610] |
3.14[611] |
89 |
HLA-DQB1 |
HLA class II histocompatibility antigen, DQ beta 1 chain |
[612] |
-3.98[613] |
[614] |
[615] |
-2.54[616] |
[617] |
0.26[618] |
90 |
HLA-DQA2 |
HLA class II histocompatibility antigen, DQ alpha 2 chain |
[619] |
[620] |
[621] |
[622] |
-7.49[623] |
[624] |
-2.25[625] |
91 |
INPP5D |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 |
[626] |
4.82[627] |
5.34[628] |
-4.84[629] |
-4.42[630] |
-1.53[631] |
2.50[632] |
92 |
PTPRC |
Receptor-type tyrosine-protein phosphatase C |
[633] |
[634] |
[635] |
[636] |
1.62[637] |
-7.36[638] |
4.37[639] |
93 |
PLCG2 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase gamma-2 |
-0.31[640] |
-5.93[641] |
1.53[642] |
-1.49[643] |
-0.40[644] |
3.94[645] |
94 |
TRAF6 |
TNF receptor-associated factor 6 |
[646] |
2.06[647] |
2.08[648] |
2.65[649] |
2.91[650] |
2.30[651] |
4.13[652] |
95 |
WAS |
Wiskott-Aldrich syndrome protein |
[653] |
-4.75[654] |
-4.07[655] |
-0.62[656] |
-2.26[657] |
-3.37[658] |
0.81[659] |
96 |
LCP2 |
Lymphocyte cytosolic protein 2 |
[660] |
[661] |
[662] |
[663] |
-2.46[664] |
[665] |
2.37[666] |
97 |
LAT |
Linker for activation of T-cells family member 1 |
[667] |
-0.48[668] |
1.19[669] |
-0.40[670] |
-0.11[671] |
0.40[672] |
0.80[673] |
98 |
CD3E |
T-cell surface glycoprotein CD3 epsilon chain |
[674] |
-7.90[675] |
[676] |
-4.28[677] |
[678] |
[679] |
0.62[680] |
99 |
PAG1 |
Phosphoprotein associated with
glycosphingolipid-enriched microdomains 1 |
0.19[681] |
-0.52[682] |
6.06[683] |
4.12[684] |
5.19[685] |
5.99[686] |
100 |
CD247 |
T-cell surface glycoprotein CD3 zeta chain |
[687] |
-3.90[688] |
-4.44[689] |
-5.94[690] |
-2.26[691] |
-3.71[692] |
1.21[693] |
101 |
CD3D |
T-cell surface glycoprotein CD3 delta chain |
[694] |
2.37[695] |
0.49[696] |
-1.87[697] |
-5.25[698] |
-3.32[699] |
0.90[700] |
102 |
LCK |
Tyrosine-protein kinase Lck |
[701] |
3.75[702] |
3.96[703] |
-6.03[704] |
-3.83[705] |
-4.10[706] |
2.46[707] |
103 |
CD3G |
T-cell surface glycoprotein CD3 gamma chain |
[708] |
-2.62[709] |
-1.74[710] |
-2.79[711] |
-3.36[712] |
-2.84[713] |
0.88[714] |
104 |
ZAP70 |
Tyrosine-protein kinase ZAP-70 |
[715] |
1.97[716] |
2.32[717] |
-3.90[718] |
-4.29[719] |
-3.02[720] |
3.38[721] |
105 |
HLA-DQB2 |
HLA class II histocompatibility antigen, DQ beta 2 chain |
[722] |
[723] |
[724] |
[725] |
-2.16[726] |
[727] |
-1.73[728] |
106 |
ITK |
Tyrosine-protein kinase ITK/TSK |
[729] |
-5.93[730] |
-2.82[731] |
[732] |
1.09[733] |
-3.72[734] |
3.42[735] |
107 |
CARD11 |
Caspase recruitment domain-containing protein 11 |
[736] |
2.10[737] |
-4.28[738] |
-5.04[739] |
2.50[740] |
6.94[741] |
3.50[742] |
108 |
PTPN22 |
Tyrosine-protein phosphatase non-receptor type 22 |
[743] |
-5.69[744] |
-2.58[745] |
-2.01[746] |
0.36[747] |
5.94[748] |
3.96[749] |
109 |
PAK3 |
Serine/threonine-protein kinase PAK 3 |
[750] |
-5.44[751] |
[752] |
[753] |
-0.35[754] |
1.30[755] |
2.01[756] |
110 |
GRAP2 |
GRB2-related adapter protein 2 |
[757] |
-4.88[758] |
[759] |
-1.13[760] |
-0.73[761] |
0.24[762] |
2.06[763] |
111 |
PRKCQ |
Protein kinase C theta type |
[764] |
1.87[765] |
-1.56[766] |
[767] |
3.38[768] |
4.81[769] |
3.31[770] |
112 |
CD101 |
Immunoglobulin superfamily member 2 |
[771] |
-0.58[772] |
1.53[773] |
2.20[774] |
2.24[775] |
1.15[776] |
3.61[777] |
113 |
TRAT1 |
T-cell receptor-associated transmembrane adapter 1 |
[778] |
[779] |
[780] |
[781] |
[782] |
[783] |
4.01[784] |
114 |
SEM1 |
Putative protein SEM1, isoform 2 |
[785] |
[786] |
[787] |
[788] |
[789] |
[790] |
[791] |
115 |
HLA-DRB4 |
HLA class II histocompatibility antigen, DR beta 4 chain |
[792] |
[793] |
[794] |
[795] |
[796] |
[797] |
[798] |
116 |
PSMA8 |
Proteasome subunit alpha type-7-like |
[799] |
[800] |
[801] |
[802] |
[803] |
[804] |
[805] |
117 |
TRAV19 |
T-cell receptor alpha variable 19 (Fragment) |
[806] |
[807] |
[808] |
[809] |
[810] |
[811] |
[812] |
118 |
FYB1 |
FYN-binding protein 1 |
[813] |
[814] |
[815] |
[816] |
[817] |
[818] |
[819] |
119 |
TRBV7-9 |
T-cell receptor beta variable 7-9 (Fragment) |
[820] |
[821] |
[822] |
[823] |
[824] |
[825] |
[826] |
120 |
PSMB11 |
Proteasome subunit beta type-11 |
[827] |
[828] |
[829] |
[830] |
[831] |
[832] |
[833] |
121 |
TRAV8-4 |
T-cell receptor alpha variable 8-4 (Fragment) |
[834] |
[835] |
[836] |
[837] |
[838] |
[839] |
[840] |
122 |
HLA-DRB3 |
HLA class II histocompatibility antigen, DR beta 3 chain |
[841] |
[842] |
[843] |
[844] |
[845] |
[846] |
[847] |
123 |
TRBV12-3 |
T-cell receptor beta chain V region YT35 |
[848] |
[849] |
[850] |
[851] |
[852] |
[853] |
[854] |
124 |
TRAV29DV5 |
[855] |
[856] |
[857] |
[858] |
[859] |
[860] |
[861] |
|
|
|
|
|
|
|
|
|
|